Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26. (Record no. 28815565)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01396 a2200421 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517235250.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201902s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1879-0712 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.ejphar.2018.09.003 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Rinne, Maiju K |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190213 |
| 245 00 - TITLE STATEMENT | |
| Title | Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | European journal of pharmacology |
| Date of publication, distribution, etc. | Oct 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 137-144 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adenylyl Cyclases |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzamides |
| General subdivision | chemistry |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CHO Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Calcium |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cricetulus |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Orexin Receptors |
| General subdivision | agonists |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Orexins |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Solubility |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Type C Phospholipases |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | ets-Domain Protein Elk-1 |
| General subdivision | physiology |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Leino, Teppo O |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Turku, Ainoleena |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Turunen, Pauli M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Steynen, Yana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Xhaard, Henri |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wallén, Erik A A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kukkonen, Jyrki P |
| 773 0# - HOST ITEM ENTRY | |
| Title | European journal of pharmacology |
| Related parts | vol. 837 |
| -- | p. 137-144 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.ejphar.2018.09.003">https://doi.org/10.1016/j.ejphar.2018.09.003</a> |
| Public note | Available from publisher's website |
No items available.